DRUG vs. QQQ

Last updated Jun 23, 2026

DRUG (Bright Minds Biosciences Inc) is a stock, while QQQ (Invesco QQQ ETF) is Nasdaq-100 fund tracking the NASDAQ-100 Index. Over the past 5 years, DRUG returned 22.44%/yr vs 16.94%/yr for QQQ. At a 0.19 correlation, their price movements are largely independent.

Performance

DRUG vs. QQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bright Minds Biosciences Inc (DRUG) and Invesco QQQ ETF (QQQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DRUG achieves a -18.64% return, which is significantly lower than QQQ's 20.41% return.

DRUG

• 1D: 4.67%
• 1M: -23.96%
• YTD: -18.64%
• 6M: -23.52%
• 1Y: 132.48%
• 3Y*: 178.18%
• 5Y*: 22.44%
• 10Y*: —

QQQ

• 1D: -0.25%
• 1M: 2.96%
• YTD: 20.41%
• 6M: 19.46%
• 1Y: 40.91%
• 3Y*: 27.47%
• 5Y*: 16.94%
• 10Y*: 22.48%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DRUG vs. QQQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
DRUG Bright Minds Biosciences Inc	-18.64%	116.66%	2,418.88%	-61.35%	-76.66%	-39.45%
QQQ Invesco QQQ ETF	20.41%	20.77%	25.58%	54.86%	-32.58%	27.66%

Correlation

The correlation between DRUG and QQQ is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.28
Correlation (3Y) Calculated over the trailing 3-year period	0.20
Correlation (5Y) Calculated over the trailing 5-year period	0.19
Correlation (All Time) Calculated using the full available price history since Mar 22, 2021	0.19

Return for Risk

DRUG vs. QQQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DRUG

DRUG Risk / Return Rank: 85
DRUG Sharpe Ratio Rank: 87
DRUG Sortino Ratio Rank: 85
DRUG Omega Ratio Rank: 80
DRUG Calmar Ratio Rank: 86
DRUG Martin Ratio Rank: 86

QQQ

QQQ Risk / Return Rank: 72
QQQ Sharpe Ratio Rank: 76
QQQ Sortino Ratio Rank: 70
QQQ Omega Ratio Rank: 72
QQQ Calmar Ratio Rank: 70
QQQ Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DRUG vs. QQQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bright Minds Biosciences Inc (DRUG) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	DRUG	QQQ	Difference
Sharpe ratio: Return per unit of total volatility	1.82	2.33	-0.51
Sortino ratio: Return per unit of downside risk	2.59	3.03	-0.44
Omega ratio: Gain probability vs. loss probability	1.29	1.41	-0.12
Calmar ratio: Return relative to maximum drawdown	3.47	3.44	+0.04
Martin ratio: Return relative to average drawdown	9.08	12.79	-3.71

DRUG vs. QQQ - Sharpe Ratio Comparison

The current DRUG Sharpe Ratio is 1.82, which is comparable to the QQQ Sharpe Ratio of 2.33. The chart below compares the historical Sharpe Ratios of DRUG and QQQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

DRUG vs. QQQ - Drawdown Comparison

The maximum DRUG drawdown since its inception was -97.68%, which is greater than QQQ's maximum drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for DRUG and QQQ.

Drawdown Indicators

	DRUG	QQQ	Difference
Max Drawdown Largest peak-to-trough decline	-97.68%	-82.97%	-14.71%
Max Drawdown (1Y) Largest decline over 1 year	-38.35%	-11.96%	-26.39%
Max Drawdown (3Y) Largest decline over 3 years	-76.98%	-22.77%	-54.21%
Max Drawdown (5Y) Largest decline over 5 years	-97.68%	-35.12%	-62.56%
Max Drawdown (10Y) Largest decline over 10 years	—	-35.12%	—
Current Drawdown Current decline from peak	-33.85%	-0.99%	-32.86%
Average Drawdown Average peak-to-trough decline	-58.76%	-32.73%	-26.03%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.64%	3.21%	+11.43%

Volatility

DRUG vs. QQQ - Volatility Comparison

Bright Minds Biosciences Inc (DRUG) has a higher volatility of 18.60% compared to Invesco QQQ ETF (QQQ) at 8.47%. This indicates that DRUG's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DRUG	QQQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.60%	8.47%	+10.13%
Volatility (6M) Calculated over the trailing 6-month period	44.58%	14.20%	+30.38%
Volatility (1Y) Calculated over the trailing 1-year period	73.50%	17.67%	+55.83%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	662.99%	22.64%	+640.35%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	646.62%	22.43%	+624.19%

Dividends

DRUG vs. QQQ - Dividend Comparison

DRUG has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.49%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DRUG Bright Minds Biosciences Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
QQQ Invesco QQQ ETF	0.49%	0.45%	0.56%	0.62%	0.80%	0.43%	0.55%	0.74%	0.91%	0.84%	1.06%	0.99%

Frequently Asked Questions

Can I hold both DRUG and QQQ in my portfolio?

DRUG and QQQ have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DRUG or QQQ?

DRUG has higher volatility (18.60%) compared to QQQ (8.47%). In terms of maximum drawdown, DRUG dropped -97.68% vs QQQ's -82.97%.

Which has better risk-adjusted returns?

QQQ currently has the higher Sharpe Ratio (2.33 vs 1.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.